Thursday, November 17, 2016 12:19:57 AM
For the ones among us who don't which way Clinuvel is heading?
She is in the uptrend. Those 2 or 3 cents to the down- or upside doesn't make no difference. We all gonna win. Trading this stock on such a low volume (2185) makes absolute no sence. Don't think in pinuts, think in dollars.
Clinuvel isn't a startup anymore! She is half way becoming a grown up biotech company.
Keep in mind that still no 2% of the upcoming biotech companies get approval by the FDA or EMA! Clinuvel makes the difference.
The time has come that you don't have to follow CLVLY as closely as possible in every day Life.
Clinuvel has taken the lead right now. You can sleep well while she is doing the job!
The only thing you have to do is buy and wait. As soon as CLVLY gets to the Real Nasdaq, "trading" this stock will be great!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM